Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/05/2014CA2733359C Pyrrolo[2,3-d]pyrimidine compounds
08/05/2014CA2727847C Compositions and methods for treating corneal inflammation
08/05/2014CA2725045C Silent desensitizers of neuronal nachr and methods of use thereof
08/05/2014CA2713777C Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream
08/05/2014CA2681803C Use of oligomers of lactic acid in the treatment of gynaecological infection
08/05/2014CA2680606C Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
08/05/2014CA2677703C Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
08/05/2014CA2673193C Homogeneous paste and gel formulations
08/05/2014CA2663234C Novel phenylacetic acid derivative
08/05/2014CA2661333C Salt of phenoxypyridine derivative or crystal thereof and process for producing the same
08/05/2014CA2658976C Aminoindazolylurea derivatives
08/05/2014CA2654987C Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
08/05/2014CA2654789C Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
08/05/2014CA2654439C Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
08/05/2014CA2654315C Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and their use
08/05/2014CA2654264C Inhalant powder containing phenylalanine
08/05/2014CA2654105C Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
08/05/2014CA2653012C Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino) propan amides
08/05/2014CA2650384C Novel gem-difluorinated c-glycoside compounds derived from podophyllotoxin, their preparation and their applications
08/05/2014CA2643488C Indolopyridines as eg5 kinesin modulators
08/05/2014CA2643037C Compositions and methods for delivery of amino-functional drugs
08/05/2014CA2637417C Novel indoloquinoxaline derivatives and their use in the treatment of viral infections
08/05/2014CA2636701C Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
08/05/2014CA2634255C Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
08/05/2014CA2634112C Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
08/05/2014CA2634110C Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
08/05/2014CA2634093C Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
08/05/2014CA2632131C Ocular iontophoresis device
08/05/2014CA2630551C N-hydroxyamide derivatives and use thereof
08/05/2014CA2629244C Quinazoline derivatives for the treatment of cancer diseases
08/05/2014CA2628304C Method of refining episesamin
08/05/2014CA2611911C Installation for guiding a gas for devices used to treat granular products by drying, film-coating or coating, especially an incoming air unit, and device comprising one such installation
08/05/2014CA2611133C Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
08/05/2014CA2597430C Isoxazole combretastin derivatives for the treatment of disorders
08/05/2014CA2595170C Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
08/05/2014CA2591724C 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
08/05/2014CA2581840C Optimized vaccines to provide protection against ebola and other viruses
08/05/2014CA2565238C Amido compounds and their use as pharmaceuticals
08/05/2014CA2564112C Dalbavancin compositions for treatment of bacterial infections
08/05/2014CA2555390C Immunostimulatory viral rna oligonucleotides
08/05/2014CA2554040C Use of meloxicam for the treatment of respiratory diseases in pigs
08/05/2014CA2553886C Combined use of prame inhibitors and hdac inhibitors
08/05/2014CA2528597C Stabilized immunomodulatory oligonucleotides
08/05/2014CA2521839C Augmented cognitive training
08/05/2014CA2519092C Branched water-soluble polymers and their conjugates
08/05/2014CA2510020C Chemically modified polyaminosaccharide by a hydrocarbyl sultone compound
08/05/2014CA2497792C Cyclodextrin-based polymers for therapeutics delivery
08/05/2014CA2496681C Cyclopalladated compounds comprising bis-diphenylphosphine-ferrocene ligands, and their use in treating diseases
08/05/2014CA2361323C Nutritional supplement for the prevention and treatment of excessive intestinal permeability
07/2014
07/31/2014WO2014117176A1 Methods of improving tolerability, pharmacodynamics, and efficacy of b-alanine and use therefor
07/31/2014WO2014117117A1 Chronic nsaid treatment for fuchs endothelial corneal dystrophy
07/31/2014WO2014117090A1 Metalloenzyme inhibitor compounds
07/31/2014WO2014117089A1 Compositions and methods for the treatment of pervasive development disorders
07/31/2014WO2014117070A1 Curcumin analogs and methods of inhibiting hiv-1
07/31/2014WO2014117035A1 COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS
07/31/2014WO2014117003A1 Use of phenoxypropylamine compounds to treat depression
07/31/2014WO2014116985A1 Composition for treatment of neurodegenerative disease
07/31/2014WO2014116973A1 Compounds and methods for treating inflammatory bowel diseases
07/31/2014WO2014116962A1 Selective histone deacetylase 8 inhibitors
07/31/2014WO2014116905A2 Tissue cooling clamps and related methods
07/31/2014WO2014116876A1 Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid
07/31/2014WO2014116859A1 Methods and compositions for inhibiting human copper trafficking proteins atox1 and ccs
07/31/2014WO2014116849A1 Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
07/31/2014WO2014116845A1 Thiadiazole analogs thereof and methods for treating smn-deficiency-related-conditions
07/31/2014WO2014116787A1 Poly(nitrogen/amine) derivatives of a natural wax and ophthalmic compositions
07/31/2014WO2014116768A1 Guanidine derivatives for the treatment of hepatitis c
07/31/2014WO2014116766A1 Ammonium derivatives for the treatment of hepatitis c
07/31/2014WO2014116755A1 Uses of dihydro bases
07/31/2014WO2014116739A1 Dosage forms and therapeutic uses l-4-chlorokynurenine
07/31/2014WO2014116723A1 Multivalent liposome formulations
07/31/2014WO2014116716A1 Biocompatible polymer compositions for tissue void filling
07/31/2014WO2014116704A1 Phosphoribosyl pyrophosphate synthetase 2 (prps2) as a therapeutic target in cancer treatment
07/31/2014WO2014116684A1 Non-peptidic neuropeptide y receptor modulators
07/31/2014WO2014116652A2 Method and composition for treating spasticity
07/31/2014WO2014116651A1 Targeting gli proteins in human cancer by small molecules
07/31/2014WO2014116642A1 Two-carbon linked artemisinin-derived trioxane dimers
07/31/2014WO2014116634A1 Symmetrical marinopyrrole derivatives as potential antibiotic agents
07/31/2014WO2014116593A1 Novel traps in the treatment of macular degeneration
07/31/2014WO2014116573A1 Processes for the preparation of isotopologues of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof
07/31/2014WO2014116386A1 (22E)-2-METHYLENE-22-DEHYDRO-1α,24,25-TRIHYDROXY-19-NOR-VITAMIN D3 ANALOGS
07/31/2014WO2014116228A1 Usp14 inhibitors for treating or preventing viral infections
07/31/2014WO2014116132A1 Biomaterial comprising poly(trimethylene carbonate-co-e-caprolactone) for promoting axonall growth and neuronal regeneration
07/31/2014WO2014116070A1 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
07/31/2014WO2014115488A1 Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida
07/31/2014WO2014115487A1 Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus
07/31/2014WO2014115171A1 Triazine compounds and a process for preparation thereof
07/31/2014WO2014115170A1 Pregnane-oximino-aminoalkylethers and process for preparation thereof, useful as antidiabetic and antidyslipidemic agents
07/31/2014WO2014115127A1 Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide
07/31/2014WO2014115103A1 Composition comprising an encapsulated antagomir
07/31/2014WO2014115082A1 Pharmaceutical formulations of imatinib
07/31/2014WO2014115080A1 Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction
07/31/2014WO2014115078A1 Heterocyclic amide derivatives as p2x7 receptor antagonists
07/31/2014WO2014115072A1 Heterocyclic amide derivatives as p2x7 receptor antagonists
07/31/2014WO2014115020A1 Heterocycles and their radiolabeled analogs useful as cox-1 selective inhibitors
07/31/2014WO2014115011A1 Compositions for use in treating eye disorders using opioid receptor antagonists
07/31/2014WO2014114971A1 Increased dosage of efavirenz for the treatment of cancer
07/31/2014WO2014114929A1 Compounds and methods for treating bacterial infections
07/31/2014WO2014114928A1 Chemical compounds
07/31/2014WO2014114786A1 Pharmaceutical combinations of flurbiprofen, glucosamin and capsaicin
07/31/2014WO2014114779A1 N-substituted-5-substituted phthalamic acids as sortilin inhibitors
1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 7860